AAREYDRUGS.NS

Aarey Drugs & Pharmaceuticals Limited [AAREYDRUGS.NS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

AAREYDRUGS.NS Stock Summary

Top 10 Correlated ETFs

AAREYDRUGS.NS


Top 10 Correlated Stocks

AAREYDRUGS.NS


In the News

AAREYDRUGS.NS Financial details

Company Rating
Neutral
Market Cap
1.19B
Income
37.75M
Revenue
3.43B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
27 May 2024
P/E
65.16
Forward P/E
-
PEG
-14.53
P/S
0.47
P/B
1.3
P/C
-
P/FCF
-
Quick Ratio
1.34
Current Ratio
1.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
1.5
EPS next Y
-
EPS next Q
-
EPS this Y
-45.22%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-11.85%
Revenue last 5Y
3.15%
Revenue Q/Q
32.24%
EPS Q/Q
141.94%
-
-
-
-
SMA20
-10.6%
SMA50
-27.41%
SMA100
2.54%
Inst Own
-
Inst Trans
-
ROA
1%
ROE
4%
ROC
0.06%
Gross Margin
3%
Oper. Margin
2%
Profit Margin
1%
Payout
-
Shs Outstand
25.38M
Shs Float
9.92M
-
-
-
-
Target Price
-
52W Range
22.0-68.0
52W High
-33.82%
52W Low
+104.55%
RSI
50.28
Rel Volume
0.1
Avg Volume
113.54K
Volume
11.22K
Perf Week
13.92%
Perf Month
-5.16%
Perf Quarter
-3.54%
Perf Half Y
-7.31%
-
-
-
-
Beta
0.905
-
-
Volatility
1.58%, 3.54%
Prev Close
2.27%
Price
45
Change
-0.44%

AAREYDRUGS.NS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-03-31

Metric History 2019-03-312020-03-312021-03-312022-03-31 2023-03-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
151.68128.33148.77204.2163.19
Net income per share
2.82.482.792.721.49
Operating cash flow per share
0.291.222.34-1.87-0.5
Free cash flow per share
-0.230.831.11-2.78-0.92
Cash per share
0.160.210.283.20.44
Book value per share
37.0139.4942.2847.246.25
Tangible book value per share
37.0139.4942.2847.246.25
Share holders equity per share
37.0139.4942.2847.246.25
Interest debt per share
7.828.378.78.0615.99
Market cap
1.01B1.01B1.01B997.91M609.24M
Enterprise value
1.17B1.19B1.19B1.14B979.36M
P/E ratio
15.517.515.5615.2216.16
Price to sales ratio
0.290.340.290.20.15
POCF ratio
147.1935.4818.51-22.21-47.56
PFCF ratio
-187.9452.2939.02-14.91-26.2
P/B Ratio
1.171.11.030.880.52
PTB ratio
1.171.11.030.880.52
EV to sales
0.330.40.340.230.24
Enterprise value over EBITDA
9.6612.0710.288.159.37
EV to operating cash flow
170.1441.5721.68-25.32-76.45
EV to free cash flow
-217.2561.2745.71-16.99-42.12
Earnings yield
0.060.060.060.070.06
Free cash flow yield
-0.010.020.03-0.07-0.04
Debt to equity
0.190.190.180.150.32
Debt to assets
0.110.090.080.070.13
Net debt to EBITDA
1.31.771.5113.54
Current ratio
2.311.811.651.741.61
Interest coverage
4.263.773.555.242.33
Income quality
0.080.390.66-0.45-0.21
Dividend Yield
00000
Payout ratio
0.040000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
-1.78-0.32-0.530.490.81
Capex to revenue
00-0.0100
Capex to depreciation
-1.22-1.03-3.13-1.11-0.66
Stock based compensation to revenue
00000
Graham number
48.2746.9251.4853.7739.32
ROIC
0.060.050.060.050.03
Return on tangible assets
0.040.030.030.030.01
Graham Net
15.112.8810.7517.57-3.66
Working capital
753.6M810.66M857.66M962.47M1.02B
Tangible asset value
865.53M923.46M988.6M1.14B1.17B
Net current asset value
738.3M796.07M842.02M947.92M966.95M
Invested capital
0.190.190.180.150.32
Average receivables
1.25B1.38B1.82B2.06B2.06B
Average payables
574.29M575.14M940.45M1.1B1.18B
Average inventory
180.13M191.23M177.28M160.72M212.52M
Days sales outstanding
114.52199.22209.04157.69175.16
Days payables outstanding
39.9197.8119.2384.79115.08
Days of inventory on hand
22.7521.3819.9510.5826.05
Receivables turnover
3.191.831.752.312.08
Payables turnover
9.153.733.064.33.17
Inventory turnover
16.0517.0718.334.514.01
ROE
0.080.060.070.060.03
Capex per share
-0.53-0.39-1.23-0.91-0.41

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q3

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
24.6162.3120.0722.7830.13
Net income per share
0.190.140.290.310.75
Operating cash flow per share
0.430.160.330.320.37
Free cash flow per share
0.430.160.330.320.37
Cash per share
0.050.440.442.940
Book value per share
45.9246.2546.2546.850
Tangible book value per share
046.25046.850
Share holders equity per share
45.9246.2546.2546.850
Interest debt per share
0.2815.260.3515.220.42
Market cap
981.12M609.23M873.23M1.23B1.54B
Enterprise value
982.36M979.36M884.47M1.59B1.54B
P/E ratio
49.642.6430.1239.2220.17
Price to sales ratio
1.570.391.712.132.01
POCF ratio
89152.23104.93150.18163.09
PFCF ratio
89152.23104.93150.18163.09
P/B Ratio
0.840.520.741.040
PTB ratio
0.840.520.741.040
EV to sales
1.570.621.742.752.01
Enterprise value over EBITDA
48.9429.1243.4559.3856.95
EV to operating cash flow
89.11244.72106.28194.34163.09
EV to free cash flow
89.11244.72106.28194.34163.09
Earnings yield
0.010.010.010.010.01
Free cash flow yield
0.010.010.010.010.01
Debt to equity
00.3200.310
Debt to assets
00.1300.160
Net debt to EBITDA
0.0611.010.5513.490
Current ratio
01.6101.980
Interest coverage
2.053.111.031.82.11
Income quality
2.231.121.151.040.49
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
00000
Research and developement to revenue
00000
Intangibles to total assets
00000
Capex to operating cash flow
00000
Capex to revenue
00000
Capex to depreciation
00000
Stock based compensation to revenue
00000
Graham number
14.1912.117.2418.050
ROIC
0.01000.010
Return on tangible assets
00000
Graham Net
0.05-3.660.443.160
Working capital
1.24M1.02B11.24M1.08B0
Tangible asset value
01.17B01.19B0
Net current asset value
1.24M966.95M11.24M1.03B0
Invested capital
00.3200.310
Average receivables
668.76M993.96M993.96M696.35M696.35M
Average payables
405.6M636.65M636.65M305.48M305.48M
Average inventory
102.52M144.1M144.1M111.86M111.86M
Days sales outstanding
0113.110216.740
Days payables outstanding
072.62099.670
Days of inventory on hand
016.44036.50
Receivables turnover
00.800.420
Payables turnover
01.2400.90
Inventory turnover
05.4802.470
ROE
000.010.010
Capex per share
00000

AAREYDRUGS.NS Frequently Asked Questions

What is Aarey Drugs & Pharmaceuticals Limited stock symbol ?

Aarey Drugs & Pharmaceuticals Limited is a IN stock and trading under the symbol AAREYDRUGS.NS

What is Aarey Drugs & Pharmaceuticals Limited stock quote today ?

Aarey Drugs & Pharmaceuticals Limited stock price is $45 today.

Is Aarey Drugs & Pharmaceuticals Limited stock public?

Yes, Aarey Drugs & Pharmaceuticals Limited is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Similar Market Cap